Gene therapy for unresectable hepatocellular carcinoma using recombinant human adenovirus type 5.

about

Progress and prospects of engineered sequence-specific DNA modulating technologies for the management of liver diseases Genetic polymorphisms in antioxidant enzyme genes and susceptibility to hepatocellular carcinoma in Chinese population: a case-control study.

P2860

Q27011249-09D4F663-4A54-495E-A77D-11DFE6732DA5 Q42146970-6E3CA575-9A30-470F-A63D-5F9A74151CA2

P2860

Gene therapy for unresectable hepatocellular carcinoma using recombinant human adenovirus type 5.

Item

http://www.wikidata.org/entity/Q42208584

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Gene therapy for unresectable ...... inant human adenovirus type 5.

@en

Gene therapy for unresectable ...... inant human adenovirus type 5.

@nl

type

Item

label

Gene therapy for unresectable ...... inant human adenovirus type 5.

@en

Gene therapy for unresectable ...... inant human adenovirus type 5.

@nl

prefLabel

Gene therapy for unresectable ...... inant human adenovirus type 5.

@en

Gene therapy for unresectable ...... inant human adenovirus type 5.

@nl

P1476

Gene therapy for unresectable ...... inant human adenovirus type 5.

@en

P2093

Annan Dong

http://www.w3.org/2001/XMLSchema#string

Jun Dong

http://www.w3.org/2001/XMLSchema#string

Lujun Shen

http://www.w3.org/2001/XMLSchema#string

Peihong Wu

http://www.w3.org/2001/XMLSchema#string

Sheng Li

http://www.w3.org/2001/XMLSchema#string

Siyue Mao

http://www.w3.org/2001/XMLSchema#string

Wang Li

http://www.w3.org/2001/XMLSchema#string

Xiao Gong

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide

New data supporting modified RECIST (mRECIST) for Hepatocellular Carcinoma.

Transarterial chemoembolization with cisplatin as second-line treatment for hepatocellular carcinoma unresponsive to chemoembolization with epirubicin-Lipiodol emulsion.

Viral DNA synthesis-dependent titration of a cellular repressor activates transcription of the human adenovirus type 2 IVa2 gene

Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: available evidence and expert opinion on the use of transarterial chemoembolization.

CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment.

Adenovirus type 5 exerts genome-wide control over cellular programs governing proliferation, quiescence, and survival.

Performance status assessment in cancer patients. An inter-observer variability study.

Development of evidence-based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan.

P2888

s12032-014-0095-4

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12032-014-0095-4

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-07-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1015622077

http://www.w3.org/2001/XMLSchema#string

P698

24990099

http://www.w3.org/2001/XMLSchema#string

P921

Adenoviridae

gene therapy

Gene therapy for unresectable hepatocellular carcinoma using recombinant human adenovirus type 5.

about

P2860

P2860

Gene therapy for unresectable hepatocellular carcinoma using recombinant human adenovirus type 5.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P921